Related references
Note: Only part of the references are listed.Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation
Michael Y. Shapira et al.
CLINICAL INFECTIOUS DISEASES (2008)
A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR
Fabio Jose B. Cardoso et al.
JOURNAL OF MOLECULAR MODELING (2008)
Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects
Sara Asimus et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2007)
Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput inhibition screening of terpenoids
Fan He et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2007)
Willmar Schwabe Award 2006: Antiplasmodial and antitumor activity of arternisinin - From bench to bedside
Thomas Efferth
PLANTA MEDICA (2007)
Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts
Lieve Naesens et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Are currently deployed artemisinins neurotoxic?
Stephen Toovey
TOXICOLOGY LETTERS (2006)
Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV)
Marta R. Romero et al.
PLANTA MEDICA (2006)
Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin
Jan Paeshuyse et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
In vivo and mechanistic evidence of nuclear receptor CAR induction by artemisinin
U. S. H. Simonsson et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria
R McGready et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells
T Efferth
CURRENT DRUG TARGETS (2006)
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo
SJF Kaptein et al.
ANTIVIRAL RESEARCH (2006)
Effects of artemisinin, artemether, arteether on the pharmacokinetics of carbamazepine
M Sukhija et al.
PHARMACOLOGY (2006)
Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an in vitro replicative system
MR Romero et al.
ANTIVIRAL RESEARCH (2005)
Toxic brainstem encephalopathy after artemisinin treatment for breast cancer
LA Panossian et al.
ANNALS OF NEUROLOGY (2005)
Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans
TE Bapiro et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Antimalarial artemisinin drugs induce cytochrome p450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor
O Burk et al.
MOLECULAR PHARMACOLOGY (2005)
Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C virus
C Fillebeen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction
T Gordi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy
T Efferth
DRUG RESISTANCE UPDATES (2005)
RICK activates a NF-κB-dependent anti-human cytomegalovirus response
J Eickhoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus
D Durantel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Development of QSAR models to predict and interpret the biological activity of artemisinin analogues
R Guha et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2004)
Quantitative structure -: Activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-κB
B Siedle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Highly antimalaria-active artemisinin derivatives: Biological activity does not correlate with chemical reactivity
RK Haynes et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
Identification of human cytochrome P450s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data
XQ Li et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents
VE Buckwold et al.
ANTIVIRAL RESEARCH (2003)
Molecular modes of action of artesunate in tumor cell lines
T Efferth et al.
MOLECULAR PHARMACOLOGY (2003)
Characterisation of the human liver in vitro metabolic pattern of artemisinin and auto-induction in the rat by use of nonlinear mixed effects modelling
USH Svensson et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2003)
Artemisinin: mechanisms of action, resistance and toxicity
SR Meshnick
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2002)
Cytochrome P450 1A1/2 induction by antiparasitic drugs:: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells
TE Bapiro et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
NF-κB -: A potential therapeutic target for inhibition of human cytomegalovirus (re)activation?
S Prösch et al.
BIOLOGICAL CHEMISTRY (2002)
Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses
T Efferth et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies
MA Avery et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria
K Stepniewska et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
Mechanisms of action of ribavirin in antiviral therapies
RC Tam et al.
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY (2001)
Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: Inhibition of PI3-K activity inhibits viral replication and virus-induced signaling
RA Johnson et al.
JOURNAL OF VIROLOGY (2001)
Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria
TQ Binh et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of β-L-2′,3′dideoxyadenosine, a potent inhibitor of HIV and HBV replication
L Placidi et al.
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY (2001)
Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes
A Marchini et al.
JOURNAL OF VIROLOGY (2001)
Pharmacokinetic interactions of antimalarial agents
PT Giao et al.
CLINICAL PHARMACOKINETICS (2001)
Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents
M Marschall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Terpenoids and flavonoids from Artemisia species
HQ Tang et al.
PLANTA MEDICA (2000)
Arteether-induced brain injury in Macaca mulatta.: I.: The precerebellar nuclei:: the lateral reticular nuclei, paramedian reticular nuclei, and perihypoglossal nuclei
JM Petras et al.
ANATOMY AND EMBRYOLOGY (2000)
Share Paper
